drugset / Trial / NCT04839055
The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC
Phase 1/2
Unknown
50 enrolled
Jiangnan University
Affiliated Hospital of Jiangnan University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare the therapy effects and clinical safety of a regulatory metabolic compound, coenzyme A (CoA) with a marketed drug, abiraterone, in Chinese patients with castration-resistant prostate cancer (CRPC) .
Timeline
- Start
- 2021-03-18
- Primary completion
- 2021-04-01
- Completion
- 2021-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Abiraterone acetate | Small molecule | 4 unknown | — |
| Subject | Coenzyme A | Small molecule | 200 iu | — |